Swiss National Bank
BIVV

Swiss National Bank’s Bioverativ Inc. Common Stock BIVV Stock Holding History

Swiss National Bank’s Portfolio BIVV Stock Details BIVV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-175,000
Closed -$9.44M – 2491
2017
Q4 		$9.44M Buy
175,000
+4,100
+2% +$224K 0.01% 724
2017
Q3 		$9.75M Hold
170,900
– – 0.01% 695
2017
Q2 		$10.3M Sell
170,900
-10,900
-6% -$621K 0.01% 673
2017
Q1 		$9.9M Buy
+181,800
New +$8.95M 0.01% 681

Other funds holding BIVV

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
ACS
Archford Capital Strategies Swansea, Illinois $987M AUM 29.31% 1-Year Est. Return

Swiss National Bank's BIVV Position: Q1 2018 in Review

Swiss National Bank sold out of Bioverativ Inc. Common Stock (BIVV) in Q1 2018, closing a stake of 175,000 shares — an estimated $9.44M sold.

Swiss National Bank first reported a position in BIVV in Q1 2017 and held it in 4 quarters. The position peaked at $10.3M in Q2 2017. 2 funds tracked by Wall St. Rank hold BIVV as of Q1 2018.

  • Swiss National Bank reported no remaining Bioverativ Inc. Common Stock position as of Q1 2018 after selling out during the quarter.
  • Swiss National Bank sold 175,000 Bioverativ Inc. Common Stock shares in Q1 2018, an estimated $9.44M.
  • Swiss National Bank first reported a position in Bioverativ Inc. Common Stock in Q1 2017 and held it in 4 quarters.
  • Swiss National Bank's Bioverativ Inc. Common Stock position peaked at $10.3M in Q2 2017.
  • 2 funds tracked by Wall St. Rank held Bioverativ Inc. Common Stock as of Q1 2018.

Based on Swiss National Bank's 13F filing for Q1 2018, filed 4 May 2018.